GENES BRAIN AND BEHAVIOR is a leading journal published by Wiley that focuses on the intricate interplay between genetic factors and behavioral neuroscience. With a robust ISSN of 1601-1848 and an E-ISSN of 1601-183X, this journal serves as a premier platform for innovative research that spans across multiple fields including genetics, neurology, and behavioral neuroscience. Recognized for its significant impact with a 2023 categorization of Q1 in Behavioral Neuroscience and Q2 in both Genetics and Neurology, GENES BRAIN AND BEHAVIOR asserts itself as an influential resource for scholars, practitioners, and students alike, facilitating the advancement of knowledge in these dynamic areas. Its Scopus rankings underscore its prominence—ranking #18 in Behavioral Neuroscience and #45 in Neurology, placing it in the top percentiles among its peers. Although not an open-access journal, the rigorous peer-review process ensures high-quality publications, pivotal for those pursuing cutting-edge research and applications. With a history of convergence from 2002 to 2024, this journal continues to foster academic dialogue and discovery in the ever-evolving landscape of brain and behavioral studies.

NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

NeuroSci is an esteemed open-access journal published by MDPI, dedicated to advancing the field of neuroscience through high-quality research dissemination. Operating under the E-ISSN 2673-4087, this journal aims to foster collaboration and innovation by providing a platform for original research articles, reviews, and theoretical studies that address the complexities of the brain and nervous system. NeuroSci encourages submissions from a wide array of disciplines including cognitive neuroscience, neurobiology, neurophysiology, and neuropsychology, making it an essential resource for researchers, professionals, and students alike. With its commitment to open accessibility, NeuroSci ensures that groundbreaking findings are readily available to the global community, thereby enhancing the impact and exchange of knowledge in neuroscience. The journal is located at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, contributing to the reputation of MDPI as a leading publisher in the academic landscape.

Aging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.

Frontiers in Human Neuroscience is a premier open access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the complexities of human neuroscience. With an ISSN of 1662-5161, the journal has established its prominence in various fields, achieving a Q2 ranking in categories such as Behavioral Neuroscience, Neuropsychology and Physiological Psychology, and Psychiatry and Mental Health as of 2023. Since its inception in 2008, Frontiers in Human Neuroscience has consistently contributed to the scholarly dialogue by offering a platform for innovative research that bridges the gap between neuroscience and behavioral science. The journal's rigorous peer-review process and commitment to open access ensures that findings are readily available, promoting collaboration and progress within the academic community. With an impact on neuroscience disciplines, it stands at the forefront of the field, inviting researchers, professionals, and students alike to engage with cutting-edge studies and developments. The journal's address is located in Lausanne, Switzerland, where it continues to flourish as a hub for neurobiological exploration.

ACS Chemical Neuroscience, published by the American Chemical Society, is a premier journal dedicated to exploring the complex interactions between chemistry and neuroscience. With its ISSN 1948-7193 and a distinguished impact factor that positions it within the top quartiles across multiple categories, including Q1 in Biochemistry, Q2 in Cell Biology, and Q1 in Physiology, this journal serves as an essential platform for researchers engaged in cutting-edge studies from 2010 to 2024. Positioned within the top 15% of its field in Cognitive Neuroscience according to Scopus rankings, ACS Chemical Neuroscience strives to foster interdisciplinary collaboration, publishing significant advancements that integrate chemical concepts with neurological processes. Despite its traditional publication model, the journal is committed to maintaining rigorous peer-review standards and providing valuable insights that drive innovations in therapeutics and understanding the biochemical underpinnings of brain function. Researchers, professionals, and students alike will find in this journal a vital resource for the latest findings and methodologies in the dynamic intersection of chemistry and neuroscience.

BRAIN BEHAVIOR AND IMMUNITY is a premier academic journal published by ACADEMIC PRESS INC ELSEVIER SCIENCE, focusing on the intricate relationships between the nervous and immune systems. With an impressive impact factor and consistent ranking in the top quartile (Q1) across several categories such as Behavioral Neuroscience, Endocrine and Autonomic Systems, and Immunology, this journal stands out as a critical resource for researchers and professionals in these rapidly evolving fields. Since its inception in 1987, the journal has committed to publishing high-quality, peer-reviewed research that advances our understanding of immunological processes as they relate to behavior and mental health. Though it does not currently offer Open Access, it is widely accessible to institutional libraries and professionals, ensuring that groundbreaking research reaches a broad audience. As the field continues to expand, BRAIN BEHAVIOR AND IMMUNITY remains a vital platform for innovative studies and reviews that bridge the gap between neuroscience and immunology, making it an essential read for academics, clinicians, and students dedicated to furthering research in this interdisciplinary domain.

Neurobiology of Stress is an esteemed open-access journal dedicated to advancing the field of stress research, published by ELSEVIER SCIENCE INC. Since its inception in 2015, the journal has rapidly ascended in academic prestige, achieving a remarkable Q1 ranking across multiple categories, including Biochemistry, Cellular and Molecular Neuroscience, and Endocrinology, among others. With an impact-driven approach, it focuses on the intricate mechanisms of stress response at molecular, cellular, and systemic levels, making it an essential resource for researchers, professionals, and students alike. The journal fosters interdisciplinary collaboration and innovation, providing a platform for cutting-edge studies and critical reviews that address the complexities of stress biology. As part of its commitment to accessibility, all published articles are freely available, ensuring that groundbreaking findings reach a global audience. Join a community at the forefront of stress research and contribute to the vital conversations shaping our understanding of neurobiological processes.

Immunity & Ageing is a distinguished open access journal published by BMC, committed to advancing the understanding of the interplay between immunological processes and aging. Since its inception in 2004, this journal has established itself as a leading platform for disseminating quality research, evidenced by its Q1 rankings in both Aging and Immunology categories for 2023. With an impressive Scopus ranking that places it in the top percentile of related fields, it serves as an essential resource for researchers, professionals, and students eager to explore the nuances of immune aging and age-related diseases. The journal's open access policy ensures wide accessibility and visibility, promoting collaborative discourse and innovation across the global scientific community. Based in the United Kingdom, Immunity & Ageing is set to continue its significant contribution to the field, inviting submissions that push the boundaries of knowledge and application in immunology and gerontology.